Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (9)

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

2021

  1. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

    Journal of Hepatology, Vol. 75, Núm. 1, pp. 86-97

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2020

  1. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases

    Aging, Vol. 12, Núm. 11, pp. 10337-10358

2019

  1. (Pro)renin receptor expression increases throughout the colorectal adenoma—Adenocarcinoma sequence and it is associated with worse colorectal cancer prognosis

    Cancers, Vol. 11, Núm. 6

2018

  1. Influence of age, body mass index and comorbidity on major outcomes in acute pancreatitis, a prospective nation-wide multicentre study

    United European Gastroenterology Journal, Vol. 6, Núm. 10, pp. 1508-1518

2016

  1. Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and risk factors for esophagitis in Spain: A cross-sectional study)

    United European Gastroenterology Journal, Vol. 4, Núm. 2, pp. 229-235

2015

  1. Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España

    Gastroenterologia y Hepatologia, Vol. 38, Núm. 4, pp. 263-273

2012

  1. Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: Results of a large prospective series

    Surgical Endoscopy, Vol. 26, Núm. 1, pp. 222-229